You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 7,135,465


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,135,465
Title:Sustained release beadlets containing stavudine
Abstract:Extended dosage forms of stavudine are provided comprising beadlets formed by extrusion-spheronization and coated with a seal coating. The beadlets are also coated with a modified release coating such that a hard gelatin capsule containing such beadlets will provide blood levels of stavudine over approximately 24 hours. The beadlets are prepared from a dry blend of stavudine, a spheronizing agent, a suitable diluent and a stabilizing amount of magnesium stearate. The magnesium stearate, in contrast to other similar pharmaceutical adjuncts, has been found to stabilize stavudine against degradation due to hydrolysis in the presence of the limited amount of water necessary for the extrusion-spheronization process. Also included in the scope of the invention are hard gelatin capsules containing, in addition to the stavudine beadlets, similar beadlets containing other therapeutic agents utilized to treat retroviral infections.
Inventor(s): Abramowitz; Robert (West Windsor, NJ), O'Donoghue; Denise M. (Hightstown, NJ), Jain; Nemichand B. (West Windsor, NJ)
Assignee: Bristol-Myers Squibb Company (Princeton, NJ)
Application Number:09/821,103
Patent Claim Types:
see list of patent claims
Dosage form; Use; Process;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,135,465

Introduction

Patent 7,135,465, like any other patent, is a complex document that outlines the invention, its claims, and the scope of protection it affords. To delve into the details of this patent, it is crucial to understand the broader context of patent law, the specific claims made, and how these claims fit into the patent landscape.

Patent Law Basics

In the United States, patents are governed by the Patent Act, specifically 35 U.S.C. § 101, which states that anyone who invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any improvement thereof, may obtain a patent[2].

Patent Eligibility Under § 101

The Supreme Court has established that certain subject matters are not patentable, including "laws of nature, natural phenomena, and abstract ideas." The "Alice test" is a two-step process to determine patent eligibility:

  • Step One: Determine if the claims are directed to an abstract idea.
  • Step Two: If they are, determine if the claims include elements that transform them into a patent-eligible application by being "significantly more" than the abstract idea itself[2].

The Patent in Question: 7,135,465

To analyze the scope and claims of this patent, we need to look at its specific content.

Claim Structure

Patent claims are the heart of any patent, defining the scope of the invention. Claims can be independent or dependent, with independent claims standing alone and dependent claims referring back to an independent claim. The length and count of independent claims can be metrics for measuring patent scope, as they often correlate with patent maintenance payments, forward citations, and the breadth of patent classes[4].

Claim Analysis

For Patent 7,135,465, a detailed analysis would involve examining each claim to understand what is being protected. Here are some key points to consider:

  • Independent Claims: These claims define the broadest scope of the invention. Analyzing their length and complexity can provide insights into the patent's breadth.
  • Dependent Claims: These claims narrow down the invention by adding specific limitations to the independent claims. They help in understanding the various aspects of the invention that are protected.

Example from Similar Cases

In cases like Electric Power Group, LLC v. Alstom S.A., the court analyzed claims that involved collecting, analyzing, and displaying data. The court determined that such claims were directed to an abstract idea and lacked an inventive concept, making them ineligible for patenting under § 101[3].

Scope of Protection

The scope of protection for Patent 7,135,465 is defined by its claims. Here are some aspects to consider:

  • Claim Limitations: The specific limitations included in the claims define what is protected and what is not. For instance, if a claim is limited to a particular field or application, it narrows the scope of protection.
  • Prior Art: The patent's claims must be novel and non-obvious over the prior art. Analyzing prior art can help in understanding the unique contributions of the invention.

Patent Landscape

The patent landscape includes all related patents and applications that may impact the validity or enforceability of Patent 7,135,465.

  • Global Dossier: Tools like the Global Dossier provided by the USPTO can help in identifying related applications and office actions, which can be crucial in understanding the patent's position within the broader patent landscape[5].
  • Forward and Backward Citations: Analyzing forward and backward citations can provide insights into the patent's influence and its relationship with other inventions in the field.

Litigation and Enforcement

Patents like 7,135,465 can be involved in litigation, as seen in cases like Contour IP Holding LLC v. GoPro, Inc.. Here, the court's interpretation of the claims and their eligibility under § 101 can significantly impact the outcome of such cases[2].

Key Takeaways

  • Patent Claims: The claims are the most critical part of a patent, defining its scope and protection.
  • Patent Eligibility: Claims must pass the Alice test to be eligible for patenting.
  • Scope of Protection: The scope is defined by the claims and their limitations.
  • Patent Landscape: Understanding related patents and applications is essential for navigating the patent landscape.
  • Litigation: The interpretation of claims in litigation can significantly impact the patent's validity and enforceability.

FAQs

  1. What is the Alice test in patent law? The Alice test is a two-step process to determine if a patent claim is directed to patent-eligible subject matter. It involves determining if the claim is directed to an abstract idea and, if so, whether it includes elements that transform it into a patent-eligible application[2].

  2. How do independent and dependent claims differ? Independent claims stand alone and define the broadest scope of the invention, while dependent claims refer back to an independent claim and narrow down the invention by adding specific limitations[4].

  3. What is the Global Dossier, and how is it useful? The Global Dossier is a service provided by the USPTO that allows users to access file histories of related applications from participating IP Offices. It helps in identifying related applications, office actions, and other relevant data[5].

  4. Why is prior art important in patent analysis? Prior art is crucial because it helps determine the novelty and non-obviousness of the invention. Claims must be novel and non-obvious over the prior art to be valid[3].

  5. How do forward and backward citations impact a patent's analysis? Forward citations indicate the influence of the patent on subsequent inventions, while backward citations show the relationship with earlier inventions. This analysis can provide insights into the patent's significance and its place within the patent landscape.

Sources

  1. BitLaw - Patent Law in the United States
  2. CAFC - Contour IP Holding LLC v. GoPro, Inc.
  3. CAFC - Electric Power Group, LLC v. Alstom S.A.
  4. SSRN - Patent Claims and Patent Scope
  5. USPTO - Search for patents

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,135,465

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.